Edition:
United Kingdom

People: Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

2.89CAD
23 Jul 2019
Change (% chg)

$-0.07 (-2.36%)
Prev Close
$2.96
Open
$2.96
Day's High
$2.96
Day's Low
$2.87
Volume
29,450
Avg. Vol
112,878
52-wk High
$4.94
52-wk Low
$2.30

Lebioda, Kenneth 

Mr. Kenneth Lebioda, BA, serves as Senior Vice President - Business & Corporate Development of Resverlogix Corp. He served as Senior Manager Market Access and Health Policy, Bristol-Myers Squibb from 1999 to 2004.

Basic Compensation

Total Annual Compensation, USD 218,750
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 109,485
Fiscal Year Total, USD 328,235

Options Compensation

  Quantity Market Value
Exercisable 97,500 535,400.00
Unexercisable 32,500 39,900.00
Exercised -- --